| Anthony Menendez, MD | |
|
3550 Mullan Rd, Suite 103, Missoula, MT 59808-5168 | |
| (406) 728-8420 | |
| Not Available |
| Full Name | Anthony Menendez |
|---|---|
| Gender | Male |
| Speciality | Anesthesiology |
| Experience | 32 Years |
| Location | 3550 Mullan Rd, Missoula, Montana |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1477542421 | NPI | - | NPPES |
| 0100130 | Medicaid | MT |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207L00000X | Anesthesiology | 8241 (Montana) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| St. Patrick Hospital | Missoula, MT | Hospital |
| Community Medical Center | Missoula, MT | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Missoula Anesthesiology Pc | 5597669960 | 48 |
News Archive
Neuralstem, Inc. announced this morning that it has filed an Investigational New Drug (IND) application with the U.S. Food and Drug Administration (FDA) to begin a clinical trial to treat amyotrophic lateral sclerosis (ALS or Lou Gehrig's disease).
Researchers at 17 medical centers across the country soon will begin using the hormone progesterone to treat patients who experience traumatic brain injury (TBI). The treatment is part of a randomized, double-blind Phase III clinical trial that will enroll approximately 1,140 people over a three- to six-year period beginning in March, 2010. The trial is funded by a grant to Emory University from the National Institutes of Health.
Mitochondria, tiny structures within each cell that regulate metabolism and energy use, may be a promising new target for cancer therapy, according to a new study. Manipulation of two biochemical signals that regulate the numbers of mitochondria in cells could shrink human lung cancers transplanted into mice, a team of Chicago researchers report in the journal FASEB.
A global analysis of brain proteins over a 10-week period in a mouse model of Huntington Disease has revealed some new insights into this complex neurodegenerative disorder.
› Verified 5 days ago
| Entity Name | Missoula Anesthesiology Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1710931225 PECOS PAC ID: 5597669960 Enrollment ID: O20040324001699 |
News Archive
Neuralstem, Inc. announced this morning that it has filed an Investigational New Drug (IND) application with the U.S. Food and Drug Administration (FDA) to begin a clinical trial to treat amyotrophic lateral sclerosis (ALS or Lou Gehrig's disease).
Researchers at 17 medical centers across the country soon will begin using the hormone progesterone to treat patients who experience traumatic brain injury (TBI). The treatment is part of a randomized, double-blind Phase III clinical trial that will enroll approximately 1,140 people over a three- to six-year period beginning in March, 2010. The trial is funded by a grant to Emory University from the National Institutes of Health.
Mitochondria, tiny structures within each cell that regulate metabolism and energy use, may be a promising new target for cancer therapy, according to a new study. Manipulation of two biochemical signals that regulate the numbers of mitochondria in cells could shrink human lung cancers transplanted into mice, a team of Chicago researchers report in the journal FASEB.
A global analysis of brain proteins over a 10-week period in a mouse model of Huntington Disease has revealed some new insights into this complex neurodegenerative disorder.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Anthony Menendez, MD Po Box 17527, Missoula, MT 59808-7527 Ph: (406) 728-8420 | Anthony Menendez, MD 3550 Mullan Rd, Suite 103, Missoula, MT 59808-5168 Ph: (406) 728-8420 |
News Archive
Neuralstem, Inc. announced this morning that it has filed an Investigational New Drug (IND) application with the U.S. Food and Drug Administration (FDA) to begin a clinical trial to treat amyotrophic lateral sclerosis (ALS or Lou Gehrig's disease).
Researchers at 17 medical centers across the country soon will begin using the hormone progesterone to treat patients who experience traumatic brain injury (TBI). The treatment is part of a randomized, double-blind Phase III clinical trial that will enroll approximately 1,140 people over a three- to six-year period beginning in March, 2010. The trial is funded by a grant to Emory University from the National Institutes of Health.
Mitochondria, tiny structures within each cell that regulate metabolism and energy use, may be a promising new target for cancer therapy, according to a new study. Manipulation of two biochemical signals that regulate the numbers of mitochondria in cells could shrink human lung cancers transplanted into mice, a team of Chicago researchers report in the journal FASEB.
A global analysis of brain proteins over a 10-week period in a mouse model of Huntington Disease has revealed some new insights into this complex neurodegenerative disorder.
› Verified 5 days ago
August Denicco, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 2825 Stockyard Rd Ste I-200, Missoula, MT 59808 Phone: 406-728-8420 Fax: 406-541-8430 | |
Teresa Ann Garland, M.D. Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 3550 Mullan Rd, Suite 103, Missoula, MT 59808 Phone: 406-728-8420 | |
Alistair James Macdonald, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 3550 Mullan Rd, Suite 103, Missoula, MT 59808 Phone: 406-728-8420 | |
Bruce Allen Bollen, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 3550 Mullan Rd, Suite 103, Missoula, MT 59808 Phone: 406-728-8420 | |
John Kirkeide, M.D. Anesthesiology Medicare: Medicare Enrolled Practice Location: 3550 Mullan Rd, Suite 103, Missoula, MT 59808 Phone: 406-728-8420 | |
Jason B. Tingey, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 2825 Stockyard Rd, Bldg I-200, Missoula, MT 59808 Phone: 406-728-8420 Fax: 406-541-8430 | |
Cordel A Anderson, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 2825 Stockyard Rd, Bldg I-200, Missoula, MT 59808 Phone: 406-728-8420 Fax: 406-541-8430 |